Recombinant tissue plasminogen activator reduces infarct size after reversible thread occlusion of middle cerebral artery in mice.
about
Therapeutic hypothermia for acute brain injuriesRecombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-AnalysisDynamic changes of ADC, perfusion, and NMR relaxation parameters in transient focal ischemia of rat brain.Effect of thrombolysis on the dynamics of infarct evolution after clot embolism of middle cerebral artery in mice.Tissue plasminogen activator protects hippocampal neurons from oxygen-glucose deprivation injury.Role of thrombolytic agents in cardiac arrest.Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke.Serine protease inhibitors: novel therapeutic targets for stroke?Optical Microangiography: A Label Free 3D Imaging Technology to Visualize and Quantify Blood Circulations within Tissue Beds in vivo.Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke.Animal models of ischemic stroke. Part two: modeling cerebral ischemia.Comparative study among three different methods of bone marrow mesenchymal stem cell transplantation following cerebral infarction in rats.Comparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA.The two pathophysiologies of focal brain ischemia: implications for translational stroke research.Signaling, delivery and age as emerging issues in the benefit/risk ratio outcome of tPA For treatment of CNS ischemic disorders.Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury.Development of a rat model of photothrombotic ischemia and infarction within the caudoputamen.Inhibition of Factor XII-Mediated Activation of Factor XI Provides Protection Against Experimental Acute Ischemic Stroke in Mice.Tissue plasminogen activator mediates deleterious complement cascade activation in stroke.Brain injury and cerebrovascular fibrin deposition correlate with reduced antithrombotic brain capillary functions in a hypertensive stroke model.Tissue-type plasminogen activator is involved in the process of neuronal death induced by oxygen-glucose deprivation in culture.Tissue-type plasminogen activator has paradoxical roles in focal cerebral ischemic injury by thrombotic middle cerebral artery occlusion with mild or severe photochemical damage in mice.Recombinant tissue plasminogen activator attenuates basal lamina antigen loss after experimental focal cerebral ischemia.Tissue-type plasminogen activator as a therapeutic target in stroke
P2860
Q26863644-6E2CF35D-AC3C-4A28-B737-09F0C1D58C95Q28552445-AC9F43FD-0694-4820-8AB2-3BBFEEB907B3Q30667382-572E15E5-92CF-4304-9516-FC27E62D68B7Q30948637-69C77BA5-BD1B-41C1-9AA1-F91694483965Q32063592-B23C7FFE-CE04-4E41-8C7E-055F99202E83Q33258227-D83E93FB-0144-411A-9F10-A1391545FCDAQ33879440-1CAAED45-F5DF-4AEB-90AA-087F956F73BEQ33926785-6E9C535B-C8EC-416D-8785-0EB3172245AFQ34011858-CA5412A3-2B80-483C-B4E2-83791584C22EQ34017153-D3A9C285-95EF-49BE-AB5A-4FDB20522EABQ34072182-44D29C46-FD51-44B4-94D7-0C62029794E7Q34604523-ACBDB885-460F-4342-8F4A-B878FCBEE352Q35587581-8DD95CA9-CEE0-4744-A1A8-F4B3DF22E5BDQ36079309-CF7F4E6E-A0BE-4D8A-859E-E00ECDEAD854Q36307742-CBBDB04D-8F99-4FEC-BEE9-1DAF50B76654Q36327527-709D49E7-9FEC-4CDE-B238-9AA028BE642BQ37216468-6D879841-E3BA-4A98-87E5-EED1A0678864Q40167914-ABD36EB0-43F7-429C-9C35-6231E8206F1EQ40994292-5A54036D-2A30-4260-B02D-1CBC98411D1CQ41747276-C6F2D527-B8DE-424C-B291-AF7D4E04D417Q43697767-458BFD5E-B7F7-405C-98C8-680122B258BDQ48589075-A9B06898-3768-4493-9F99-0E5EC50D2CE1Q48930059-1D132C99-4194-4566-AA5F-010F0F6B66CDQ56336828-E9BEACF3-9DE6-4260-A2C0-D617FF377956
P2860
Recombinant tissue plasminogen activator reduces infarct size after reversible thread occlusion of middle cerebral artery in mice.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Recombinant tissue plasminogen ...... iddle cerebral artery in mice.
@ast
Recombinant tissue plasminogen ...... iddle cerebral artery in mice.
@en
type
label
Recombinant tissue plasminogen ...... iddle cerebral artery in mice.
@ast
Recombinant tissue plasminogen ...... iddle cerebral artery in mice.
@en
prefLabel
Recombinant tissue plasminogen ...... iddle cerebral artery in mice.
@ast
Recombinant tissue plasminogen ...... iddle cerebral artery in mice.
@en
P2093
P1433
P1476
Recombinant tissue plasminogen ...... iddle cerebral artery in mice.
@en
P2093
P304
P356
10.1097/00001756-199901180-00021
P577
1999-01-01T00:00:00Z